| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/29/2009 | EP2081936A2 Pyrrolotriazine kinase inhibitors |
| 07/29/2009 | EP2081935A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 07/29/2009 | EP2081933A1 Pyrazolopyrimidines as p13k lipid kinase inhibitors |
| 07/29/2009 | EP2081931A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 07/29/2009 | EP2081913A2 Benzimidazole,benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof |
| 07/29/2009 | EP1771177A4 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/29/2009 | EP1756115A4 A new route to formyl-porphyrins |
| 07/29/2009 | EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 07/29/2009 | EP1713809B1 Dimeric azacyclic compounds and their use |
| 07/29/2009 | EP1678166B1 Protein kinase inhibitors |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | CN101495481A Pyrazolo [1, 5-alpha] pyrimidines as CDK inhibitors |
| 07/29/2009 | CN101495480A Constrained compounds as cgrp-receptor antagonists |
| 07/29/2009 | CN101492450A Coumarin-porphyrin schiff base compounds and preparation method |
| 07/29/2009 | CN101492383A Process for making chiral 1,4-disubstituted piperazines |
| 07/29/2009 | CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities |
| 07/29/2009 | CN100519560C Porphyrin/phthalocyanine dimer and tetramer directly bonded at pi system and processes for producing the same |
| 07/29/2009 | CN100519559C 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 07/29/2009 | CN100519555C Novel indole derivative for alkylating specific base sequence of DNA, alkylating agent using the same and medicament |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519509C Method for the continuous synthesis of methylamines |
| 07/28/2009 | US7566784 Bicyclic heterocycles as kinase inhibitors |
| 07/28/2009 | US7566779 1,1'-bi-{4,6-bis(trimethylsilyl)naphthyl}}-2,2'-dimethyl]a- mmonium bromide; reaction of the 2,2'-bishalomethyl binaphthyl with ammonia; chiral phase transfer catalyst easily extracted with a perfluorocarbon solvent for recycle; for stereoselective alkylation of a iminoglycine ester with a alkyl halide |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566722 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566713 Immuno inhibitory heterocyclic compounds |
| 07/28/2009 | US7566711 Dimethylcarbamic acid 4-(2-allyl,1-benzylcarbamoyl,8-(2,4-difluorobenzyl)-4,7-dioxo-octahydropyrazino(2,1-c)(1,2,4)triazin-6-yl)methylphen-4-yl ester; combinatorial libraries; anticarcinogenic agents; colorectal cancer; cell growth regulation; antiproliferiative/-apoptosis agents; Wnt transcription |
| 07/28/2009 | US7566708 Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/23/2009 | WO2009091939A1 Imidazopyrazinol derivatives for the treatment of cancers |
| 07/23/2009 | WO2009091788A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 07/23/2009 | WO2009091374A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 07/23/2009 | WO2009090055A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2009090054A1 Substituted sulfonamide derivatives |
| 07/23/2009 | WO2008127591A3 Pyrimidinedione derivatives and use thereof |
| 07/23/2009 | US20090187028 Process for preparing Chiral Dipeptidyl Peptidase -IV Inhibitor Intermediates |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186899 Substituted Sulfonamide Compounds |
| 07/23/2009 | US20090186898 Inhibitors of bruton's tyrosine kinase |
| 07/23/2009 | US20090186888 Novel fused pyrrolocarbazoles |
| 07/23/2009 | US20090186882 Cgrp receptor antagonists |
| 07/23/2009 | US20090186880 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 07/23/2009 | US20090186879 Tricyclic compounds and use thereof |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090185973 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/23/2009 | US20090184313 Materials for organic electroluminescent devices |
| 07/23/2009 | CA2712783A1 Beta-lactamase inhibitors |
| 07/23/2009 | CA2712267A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 07/23/2009 | CA2712266A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712265A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712141A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/22/2009 | EP2080762A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 07/22/2009 | EP2079747A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 07/22/2009 | EP2079746A2 Imidazopyrazines as protein kinase inhibitors |
| 07/22/2009 | EP2079745A1 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 07/22/2009 | EP2079744A1 Imidazopyridazines as pi3k lipid kinase inhibitors |
| 07/22/2009 | EP2079740A2 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/22/2009 | EP2079736A1 Substituted triazoles useful as axl inhibitors |
| 07/22/2009 | EP2079728A1 N-aryl pyrazole compounds for use against diabetes |
| 07/22/2009 | EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/22/2009 | EP1984372B1 Organic compound, anisotropic optical film and method of production thereof |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | CN101490054A Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 07/22/2009 | CN101490053A Bicyclic heteroaryl compounds |
| 07/22/2009 | CN101486711A 2,3-diaryl pyrimidine [1,2-a]benzimidazole heterocyclic compound, preparation and use thereof |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/21/2009 | US7563890 Synthons; nanomembranes |
| 07/21/2009 | US7563800 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors |
| 07/21/2009 | US7563799 preferential enzyme inhibitors comprising fused pyrazolo derivatives, used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease |
| 07/21/2009 | US7563798 3-(1-Methyl-pyrazol-4-yl-),4-Piperidino,7-((3-Methyl-isothiazol-5-yl)-pyrazolo(1,5-a) pyrimidine; cyclin dependent kinase inhibitors; anticarcinogenic agents; antiinflammatory agents; antiarthritic agents; viricides; neurodegenerative diseases; Alzheimer's disease;cardiovascular diseases; fungicides |
| 07/21/2009 | US7563797 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| 07/21/2009 | US7563796 8-(4-Tert-butylphenyl)-8-phenyl-2,3,4,8-tetrahydroimidazol[1, 5-a]pyrimidin-6-amine; Alzheimer's disease; treating beta-amyloid deposits and neurofibrillary tangles; Sown syndrome; dementia; neurodenerative diseases; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; cognition activators |
| 07/21/2009 | US7563791 6-(Methoxymethyl)-5-(4-nitrophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine; antiproliferative agents; angiogenesis inhibition; anticarcinogenic agents; breast cancer; colon cancer; antitumor agents |
| 07/21/2009 | US7563788 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia |
| 07/21/2009 | US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 07/21/2009 | US7563519 OLEDs doped with phosphorescent compounds |
| 07/21/2009 | CA2458339C Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 07/21/2009 | CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 07/21/2009 | CA2288789C Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 07/16/2009 | WO2009089462A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089454A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 07/16/2009 | WO2009089027A1 Phosphodiesterase inhibitors |
| 07/16/2009 | WO2009088979A1 Method of synthesizing tetrahydrobiopterin |
| 07/16/2009 | WO2009087673A1 Improved process for the manufacture of anagrelide hidrochloride monhydrate |
| 07/16/2009 | WO2009087667A2 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
| 07/16/2009 | WO2009087225A2 Pyrrolopyrimidines and pyrrolopyridines |
| 07/16/2009 | WO2009063486A3 Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone) |
| 07/16/2009 | WO2009003999A3 Chemical compounds |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | WO2008016085A9 Isoindoles, compounds prepared from the same, and processes for production of both |
| 07/16/2009 | US20090182125 Stability, reduced toxicity; covalently linked imidazole functionality |
| 07/16/2009 | US20090181990 Stable amorphous form of pemetrexed disodium |